Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drug Information Medical Encyclopedia Dictionary News Directories Other Resources

 

Medical Encyclopedia

Other encyclopedia topics:  A-Ag  Ah-Ap  Aq-Az  B-Bk  Bl-Bz  C-Cg  Ch-Co  Cp-Cz  D-Di  Dj-Dz  E-Ep  Eq-Ez  F  G  H-Hf  Hg-Hz  I-In  Io-Iz  J  K  L-Ln  Lo-Lz  M-Mf  Mg-Mz  N  O  P-Pl  Pm-Pz  Q  R  S-Sh  Si-Sp  Sq-Sz  T-Tn  To-Tz  U  V  W  X  Y  Z  0-9 

Pyruvate kinase deficiency

Printer-friendly versionEmail this page to a friend
Contents of this page:

Definition   

Pyruvate kinase deficiency is an inherited deficiency of the enzyme pyruvate kinase, which is used by red blood cells. Without this enzyme, red blood cells break down too easily, resulting in low levels of these cells (hemolytic anemia).

Causes, incidence, and risk factors   

Pyruvate kinase deficiency is transmitted as an autosomal recessive trait, which means that a child must get the defective gene from both parents to develop the disorder.

There are many different types of enzymatic defects of the red blood cell which can cause hemolytic anemia. Pyruvate kinase deficiency is the second most common cause of enzymatic-related hemolytic anemia. (G-6-PD deficiency is the number one cause.)

Pyruvate kinase deficiency may produce mild or severe hemolysis and anemia. Problems may first appear in the newborn as prolonged jaundice and anemia. Older children may be pale (due to anemia) and have intermittent episodes of jaundice. Occasionally, it is not discovered until adulthood in mild cases.

Although pyruvate kinase deficiency is found in people of all ethnic backgrounds, certain populations, such as the Amish, have a somewhat higher incidence.

Symptoms   

Signs and tests   

During a physical exam, the doctor will look for an enlarged spleen.

Tests include the following:

Treatment   

Blood transfusions may be needed for severe anemia. Removal of the spleen (splenectomy) may help to reduce the destruction of red blood cells; however, this should not necessarily be performed as it does not help in all cases. In newborns with dangerous levels of jaundice, an exchange transfusion is likely to be recommended.

If a splenectomy was done, the person should receive pneumococcal vaccine at recommended intervals.

Expectations (prognosis)   

The outcome varies. Some people have few or no symptoms, others have severe symptoms. Treatment is usually successful in reducing the severity of symptoms.

Complications   

Gallstones, composed of bilirubin produced in excess during hemolytic anemia, are a common problem. Severe pneumococcal disease following splenectomy is a possible complication.

Calling your health care provider   

See your health care provider if jaundice occurs at any time; this is a symptom of many severe illnesses.

See your health care provider if you have a family history of this disorder and are planning a pregnancy.

Prevention   

Genetic counseling is of value to prospective parents with a family history of pyruvate kinase deficiency. People who carry the gene can often be diagnosed by the presence of decreased RBC pyruvate kinase activity in their red blood cells.

Update Date: 7/26/2004

Updated by: Douglas R. Stewart, M.D., Division of Medical Genetics, Hospital of the University of Pennsylvania, Philadelphia, PA. Review provided by VeriMed Healthcare Network.

adam.com logo

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2002 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.